abstract |
Abuse of the solid dose formulation containing 5-({[2-amino-3-(4-aminocarbamimido-2,6-dimethyl-phenyl)-propenyl]-[1-(4 -Phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and methods for preparing and administering these formulations. |